A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement
Original Article
G.D. Dangas, J.G. Tijssen, J. Wöhrle, L. Søndergaard, M. Gilard, H. Möllmann, R.R. Makkar, H.C. Herrmann, G. Giustino, S. Baldus, O.D. Backer, A.H. Guimarães, L. Gullestad, A. Kini, D.v. Lewinski, M. Mack, R. Moreno, U. Schäfer, J. Seeger, D. Tchétché, K. Thomitzek, M. Valgimigli, P. Vranckx, R.C. Welsh, P. Wildgoose, A.A. Volkl, A. Zazula, R.G.v. Amsterdam, R. Mehran, and S. Windecker
N Engl J Med 2020;382:120-129
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, January 9, 2022 - 11:59pm.